Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Brief Research Report

Published on 08 Jul 2024

Advancing understanding of the role of IL-22 in myelination: insights from the Cuprizone mouse model

in Multiple Sclerosis and Neuroimmunology

Imen Zamali
Ines Elbini
Raja Rekik
Nour-Elhouda Neili
Wafa Ben Hamouda
Ahlem Ben Hmid
Raoudha Doghri
Mélika Ben Ahmed

Frontiers in Neurology

doi 10.3389/fneur.2024.1411143

1,445 views

Original Research

Published on 03 Jul 2024

Usefulness of bioelectrical impedance analysis in multiple sclerosis patients—the interrelationship to the body mass index

in Multiple Sclerosis and Neuroimmunology

Edyta Matusik

Frontiers in Neurology

doi 10.3389/fneur.2024.1409038

1,122 views

Review

Published on 03 Jul 2024

The complement system in neurodegenerative and inflammatory diseases of the central nervous system

in Multiple Sclerosis and Neuroimmunology

Luciana Negro-Demontel
Adam F. Maleki
Daniel S. Reich
Claudia Kemper

Frontiers in Neurology

doi 10.3389/fneur.2024.1396520

5,884 views
8 citations

Original Research

Published on 27 Jun 2024

Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system

in Multiple Sclerosis and Neuroimmunology

Cristina Scavone
Antonietta Anatriello
Isabella Baccari
Andrea Cantone
Daniele Di Giulio Cesare
Francesca Futura Bernardi
Ornella Moreggia
Valerio Liguori
Vincenzo Andreone
Giorgia Teresa Maniscalco

Frontiers in Neurology

doi 10.3389/fneur.2024.1383910

2,779 views
1 citation

Original Research

Published on 26 Jun 2024

A comparative study on anti-MOG and anti-AQP4 associated optic neuritis following mild COVID-19: insights from a Chinese single-center experience

in Multiple Sclerosis and Neuroimmunology

Liang Sun
Jiawei Wang
Qinglin Yang
Yanjun Guo

Frontiers in Neurology

doi 10.3389/fneur.2024.1416493

1,504 views

Original Research

Published on 21 Jun 2024

Predictive value of synaptic plasticity for functional decline in patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Carolin Balloff
Lisa Kathleen Janßen
Christian Johannes Hartmann
Sven Günther Meuth
Alfons Schnitzler
Iris-Katharina Penner
Philipp Albrecht

Frontiers in Neurology

doi 10.3389/fneur.2024.1410673

1,495 views

Systematic Review

Published on 18 Jun 2024

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series

in Multiple Sclerosis and Neuroimmunology

Cristina Scavone
Valerio Liguori
Olusola Jephthah Adungba
Daniele Di Giulio Cesare
Maria Giuseppa Sullo
Vincenzo Andreone
Liberata Sportiello
Giorgia Teresa Maniscalco
Annalisa Capuano

Frontiers in Neurology

doi 10.3389/fneur.2024.1386527

2,276 views
1 citation

Original Research

Published on 12 Jun 2024

Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain

in Multiple Sclerosis and Neuroimmunology

Gendi Wang
Xiang Chen
Xiaoyuan Wang
Yinghui Duan
Hanqing Gao
Xiaopei Ji
Yunfei Zhu
Xuanyi Xiang
Hairong Ma
Yonggang Li

Frontiers in Neurology

doi 10.3389/fneur.2024.1408759

1,467 views

Perspective

Published on 10 Jun 2024

Sex differences in Huntington's disease from a neuroinflammation perspective

in Multiple Sclerosis and Neuroimmunology

Grace Risby-Jones
John D. Lee
Trent M. Woodruff
Jenny N. Fung

Frontiers in Neurology

doi 10.3389/fneur.2024.1384480

4,165 views
4 citations

Original Research

Published on 05 Jun 2024

Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation

in Multiple Sclerosis and Neuroimmunology

Leonardo Marchi
Alice Mariottini
Vittorio Viti
Andrea Bianchi
Chiara Nozzoli
Anna Maria Repice
Riccardo Boncompagni
Andrea Ginestroni
Valentina Damato
Alessandro Barilaro

Frontiers in Neurology

doi 10.3389/fneur.2024.1373385

2,029 views
2 citations

Case Report

Published on 05 Jun 2024

A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab

in Multiple Sclerosis and Neuroimmunology

Shasha Li
Yuting Gao
Yang He
Zhaoxu Zhang

Frontiers in Neurology

doi 10.3389/fneur.2024.1371515

1,999 views

Original Research

Published on 23 May 2024

Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial

in Multiple Sclerosis and Neuroimmunology

Timothy J. Rich
Aubree Alexander
Ekaterina Dobryakova
Nancy D. Chiaravalloti
John DeLuca
Silvana L Costa

Frontiers in Neurology

doi 10.3389/fneur.2024.1393877

1,703 views

Editorial

Published on 17 May 2024

Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets

in Multiple Sclerosis and Neuroimmunology

Yang Zhou
Philippe Patrick Monnier
Jin-Zhou Feng
Shou-Gang Guo
Cong-Cong Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1427299

1,306 views

Mini Review

Published on 16 May 2024

Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review

in Multiple Sclerosis and Neuroimmunology

Rachel E. Rodin
Tanuja Chitnis

Frontiers in Neurology

doi 10.3389/fneur.2024.1415535

3,886 views
8 citations

Review

Published on 09 May 2024

Stem cell therapies: a new era in the treatment of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Lei Wu
Jing Lu
Tianye Lan
Dongmei Zhang
Hanying Xu
Zezheng Kang
Fang Peng
Jian Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1389697

14,356 views
6 citations

Original Research

Published on 01 May 2024

“A second birthday”? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation—a qualitative interview study

in Multiple Sclerosis and Neuroimmunology

Timo Volz
Anna Sippel
Felix Fischbach
Johanna Richter
Alice Grizzel Willison
Vivien Häußler
Christoph Heesen

Frontiers in Neurology

doi 10.3389/fneur.2024.1384551

2,025 views
2 citations